Literature DB >> 29275534

Skeletal fragility induced by overtreatment of adrenal insufficiency.

Henrik Falhammar1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29275534     DOI： 10.1007/s12020-017-1501-4

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  13 in total

Review 1.  MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects.

Authors:  G Mazziotti; A M Formenti; S Frara; E Roca; P Mortini; A Berruti; A Giustina
Journal:  Eur J Endocrinol       Date:  2017-06-05       Impact factor: 6.664

Review 2.  Adrenal crises: perspectives and research directions.

Authors:  R Louise Rushworth; David J Torpy; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-19       Impact factor: 3.633

Review 3.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

4.  Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.

Authors:  Valentina Camozzi; Corrado Betterle; Anna Chiara Frigo; Veronica Zaccariotto; Martina Zaninotto; Erica De Caneva; Paola Lucato; Walter Gomiero; Silvia Garelli; Chiara Sabbadin; Monica Salvà; Miriam Dalla Costa; Marco Boscaro; Giovanni Luisetto
Journal:  Endocrine       Date:  2017-08-09       Impact factor: 3.633

Review 5.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

6.  Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.

Authors:  K R Koetz; M Ventz; S Diederich; M Quinkler
Journal:  J Clin Endocrinol Metab       Date:  2011-10-12       Impact factor: 5.958

7.  Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.

Authors:  Henrik Falhammar; Helena Filipsson; Gundela Holmdahl; Per-Olof Janson; Agneta Nordenskjöld; Kerstin Hagenfeldt; Marja Thorén
Journal:  J Clin Endocrinol Metab       Date:  2007-09-18       Impact factor: 5.958

8.  Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.

Authors:  Kristian Løvås; Clara G Gjesdal; Monika Christensen; Anette B Wolff; Bjørg Almås; Johan Svartberg; Kristian J Fougner; Unni Syversen; Jens Bollerslev; Jan A Falch; Penelope J Hunt; V Krishna K Chatterjee; Eystein S Husebye
Journal:  Eur J Endocrinol       Date:  2009-03-12       Impact factor: 6.664

9.  Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency.

Authors:  Julia Schulz; Kathrin R Frey; Mark S Cooper; Kathrin Zopf; Manfred Ventz; Sven Diederich; Marcus Quinkler
Journal:  Eur J Endocrinol       Date:  2016-01-25       Impact factor: 6.664

Review 10.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958
View more
  1 in total

1.  Long-term outcomes of conventional and novel steroid replacement therapy on bone health in primary adrenal insufficiency.

Authors:  Valentina Guarnotta; Claudia Di Stefano; Carla Giordano
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.